Related Experiment Video
Updated: Jun 5, 2025

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Quality measures for the care of patients with insomnia: 2024 update after measure maintenance
Robin M Lloyd1, T'Auna Crawford2, Ryan Donald3
1Mayo Clinic, Rochester, Minnesota.
Abstract:
Insomnia is highly prevalent and is one of the most common sleep disorders among adults and children in the United States. The American Academy of Sleep Medicine convened the Quality Measures Task Force to perform maintenance on this quality measure set, developed to optimize management and care for patients with insomnia, as the measure set was originally developed and published in 2015. The Quality Measures Task Force reviewed the current medical literature, including updated clinical practice guidelines and systematic literature reviews, existing quality measures, and performance data highlighting gaps or variations in care since implementation of the original quality measure set to inform any potential revisions to the quality measures. The revised quality measures can be used to evaluate and track initial and follow-up performance measures and to implement continuous quality improvement, especially in outcomes associated with diagnosing and managing insomnia for adults and children.
Citation:
Lloyd RM, Crawford T, Donald R, et al. Quality measures for the care of patients with insomnia: 2024 update after measure maintenance. J Clin Sleep Med. 2025;21(3):565-571.
More Related Videos
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Blind Procedures
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...